Omalizumab is Effective in Symptomatic Dermographism - results of a Randomized, Placebo Controlled Trial

Publication date: Available online 4 April 2017
Source:Journal of Allergy and Clinical Immunology
Author(s): Marcus Maurer, Andrea Schütz, Karsten Weller, Nicole Schoepke, Adriane Peveling-Oberhag, Petra Staubach, Sabine Müller, Thilo Jakob, Martin Metz




http://ift.tt/2oBjHmA